The submitted projects, which may eventually become new business initiatives, include microgrids for better energy management in refugee camps, a virtual space to encourage survivors of traffic accidents to return to work, and a system to improve communication skills and quality of life for people with mental disabilities
As the EU lays the ground for its first foray into defence research, Denis Roger, Director of European synergies and innovation talks to Science|Business about what to expect from the new €90 million programme
Butterfly wings are a prime example of how flexible and elastic materials can be extremely water-repellent. The relationship between elasticity and water resistance has now been described for the first time by researchers at ETH Zurich. The new finding could help to improve water-repellent textiles for use in tents or clothing.
The annual Slush show draws 17,500 from around the world to entrepreneurship festival – highlighting the role of universities in building a tech culture in Europe
The ERC has become one of the world’s most important funders of basic research. As it approaches its 10th anniversary, a new account describes the formation and subsequent development of this beacon of excellence
Food security is at the heart of a new doctoral training collaboration between the University of Warwick and Waitrose, thanks to an award from the Biotechnology and Biological Sciences Research Council (BBSRC).
A new method for producing conductive cotton fabrics using graphene-based inks opens up new possibilities for flexible and wearable electronics, without the use of expensive and toxic processing steps.
New programme will be a “very different animal” from Horizon 2020. This is a first step - to test the waters - in carrying out defence research at a European level
An analysis of the first two years of Horizon 2020 lays bare the growing competition for EU research money. The chances of securing a grant are now around half what they were in Framework Programme 7
The UK is to ratify the Unified Patent Court Agreement. That flies in the face of prime minister Theresa May’s pledge to be free of the EU Court of Justice - and hints at a ‘soft’ Brexit
Patients completed a questionnaire assessing outcome parameters including disability progression and work capability, to assess the effectiveness of Novartis’ fingolimod (Gilenya) in the treatment of multiple sclerosis.
A study was performed at Great Ormond Street Hospital (GOSH), London and the Royal Hospital for Sick Children (RHSC) in Edinburgh to assess patient satisfaction rates and understand how to improve outcomes.
The study carried out by researchers at Aberdeen University, provides a guide to how to improve the existing PROMs feedback methods in cancer pain management.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.